STAT6 and asthma: These findings precisely parallel the epidemiologic link established between LABAs used long-term as monotherapy and loss of asthma control, suggesting that the pro-inflammatory effect of LABAs is due to augmentation of allergic inflammation and TH2 responses specifically through activation of STAT6.